VBSNZ Stock Overview
Provides medical consumer goods in Switzerland and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
IVF Hartmann Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF135.00 |
| 52 Week High | CHF141.00 |
| 52 Week Low | CHF103.00 |
| Beta | 0.48 |
| 1 Month Change | -1.46% |
| 3 Month Change | 20.54% |
| 1 Year Change | 23.85% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 26.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| VBSNZ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -1.5% | 0.8% | 1.0% |
| 1Y | 23.9% | -10.7% | 6.7% |
Return vs Industry: VBSNZ exceeded the UK Medical Equipment industry which returned -8.9% over the past year.
Return vs Market: VBSNZ exceeded the UK Market which returned 6.8% over the past year.
Price Volatility
| VBSNZ volatility | |
|---|---|
| VBSNZ Average Weekly Movement | 5.4% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: VBSNZ has not had significant price volatility in the past 3 months.
Volatility Over Time: VBSNZ's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1874 | 273 | Claus Martini | www.ivf.hartmann.info |
IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. It offers medical devices, accident prevention and hygiene products, detergents, disinfectants, body care, personal hygiene, and housekeeping products. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993.
IVF Hartmann Holding AG Fundamentals Summary
| VBSNZ fundamental statistics | |
|---|---|
| Market cap | CHF316.76m |
| Earnings (TTM) | CHF15.15m |
| Revenue (TTM) | CHF148.31m |
20.9x
P/E Ratio2.1x
P/S RatioIs VBSNZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VBSNZ income statement (TTM) | |
|---|---|
| Revenue | CHF148.31m |
| Cost of Revenue | CHF68.21m |
| Gross Profit | CHF80.10m |
| Other Expenses | CHF64.95m |
| Earnings | CHF15.15m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.36 |
| Gross Margin | 54.01% |
| Net Profit Margin | 10.21% |
| Debt/Equity Ratio | 0% |
How did VBSNZ perform over the long term?
See historical performance and comparison